Travere Therapeutics (TVTX) Revenue (2014 - 2026)
Travere Therapeutics' Revenue came in at $169.58 million for Q2 2026, up 48.2% from $114.45 million a year earlier and up 33.3% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Revenue (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Travere Therapeutics reported Revenue of $591.33 million, up 77.1% year-over-year; for FY2025, it came in at $490.73 million, up 110.5% from FY2024.
- Revenue has increased in each of the last four years, with a five-year compound annual growth rate of 19.9% (FY2020 to FY2025).
- Going back by year, Revenue was $233.18 million in FY2024 (+60.5%), $145.24 million in FY2023 (+32.7%), $109.46 million in FY2022 (+812.2%) and $12 million in FY2021 (-93.9%).
- The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q1 2014.
- Year-over-year, Revenue has increased for 15 consecutive quarters, with growth averaging 85.5% over the last eight quarters.
- The fastest year-over-year change in Revenue over five years came in Q3 2025 (growth of 162.1%), and the weakest in Q4 2021 (a decline of 76.5%).
- Business Quant data shows TVTX's Revenue at $127.2 million (Q1 2026), $129.69 million (Q4 2025) and $164.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn | 169.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 169.58 Mn |
| Mar 31, 2026 | 127.20 Mn |
| Dec 31, 2025 | 129.69 Mn |
| Sep 30, 2025 | 164.86 Mn |
| Jun 30, 2025 | 114.45 Mn |
| Mar 31, 2025 | 81.73 Mn |
| Dec 31, 2024 | 74.79 Mn |
| Sep 30, 2024 | 62.90 Mn |
| Jun 30, 2024 | 54.12 Mn |
| Mar 31, 2024 | 41.37 Mn |
| Dec 31, 2023 | 45.06 Mn |
| Sep 30, 2023 | 37.10 Mn |
| Jun 30, 2023 | 32.20 Mn |
| Mar 31, 2023 | 30.89 Mn |
| Dec 31, 2022 | 29.34 Mn |
| Sep 30, 2022 | 28.08 Mn |
| Jun 30, 2022 | 28.63 Mn |
| Mar 31, 2022 | 23.41 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | 68.22 Mn |
API Access
Travere Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();